FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023231438> ?p ?o ?g. }

• W2023231438 endingPage "27" @default.
• W2023231438 startingPage "19" @default.
• W2023231438 abstract "Malignant tumors usually involve a relatively hypoxic state, which induces overexpression of hypoxia‐inducible factor‐1α (HIF‐1α) to satisfactorily enable the tumor to survive. Thus, inhibition of the mammalian target of rapamycin (mTOR) pathway including HIF‐1α is expected to play a major role in suppression of tumor cell growth, having recently drawn much attention as an anti‐cancer therapeutic strategy for various malignant tumors. In the present study, which compared clear cell adenocarcinoma (CLA) of the ovary with serous adenocarcinoma (SEA), the immunohistochemical expression of mTOR, phosphorylated‐mTOR (p‐mTOR), HIF‐1α, and vascular endothelial growth factor (VEGF) was examined in surgically resected specimens of 29 SEA and 47 CLA. There were no significant differences in expression of mTOR, HIF‐1α and VEGF between SEA and CLA, but it was noted that p‐mTOR expression was more prominent in CLA than SEA. Then, using the cell lines of CLA (RMG‐1 and W3uF), an experimental study was designed to clarify whether tumor suppression due to downregulation of mTOR activity could represent a promising therapeutic strategy for CLA. After treatment of an analogue of rapamycin (everolimus), expression of mTOR, p‐mTOR, HIF‐1α and VEGF was examined on western blot. As a result, although mTOR expression remained unchangeable, expression of p‐mTOR, HIF‐1α and VEGF was shown to be sharply depressed. The same expression alterations were demonstrated in the xenograft model treated with everolimus. In conclusion, mTOR‐targeted therapy through usage of drugs such as everolimus may be more effective for CLA of the ovary because of its significant expression of p‐mTOR." @default.
• W2023231438 created "2016-06-24" @default.
• W2023231438 creator A5010274378 @default.
• W2023231438 creator A5011873228 @default.
• W2023231438 creator A5017594552 @default.
• W2023231438 creator A5027999170 @default.
• W2023231438 creator A5039282044 @default.
• W2023231438 creator A5042679078 @default.
• W2023231438 creator A5053051266 @default.
• W2023231438 creator A5063847492 @default.
• W2023231438 creator A5068098421 @default.
• W2023231438 creator A5080880447 @default.
• W2023231438 creator A5083631538 @default.
• W2023231438 creator A5088282685 @default.
• W2023231438 creator A5091866467 @default.
• W2023231438 date "2008-12-15" @default.
• W2023231438 modified "2023-10-16" @default.
• W2023231438 title "Therapeutic strategy targeting the mTOR-HIF-1α-VEGF pathway in ovarian clear cell adenocarcinoma" @default.
• W2023231438 cites W1569162678 @default.
• W2023231438 cites W1591132661 @default.
• W2023231438 cites W1902994240 @default.
• W2023231438 cites W1966998283 @default.
• W2023231438 cites W1968109047 @default.
• W2023231438 cites W1978999986 @default.
• W2023231438 cites W1980451446 @default.
• W2023231438 cites W1986763334 @default.
• W2023231438 cites W1997841964 @default.
• W2023231438 cites W2001877789 @default.
• W2023231438 cites W2002038224 @default.
• W2023231438 cites W2017082986 @default.
• W2023231438 cites W2017292316 @default.
• W2023231438 cites W2017605860 @default.
• W2023231438 cites W2021115479 @default.
• W2023231438 cites W2024834452 @default.
• W2023231438 cites W2034881067 @default.
• W2023231438 cites W2043518634 @default.
• W2023231438 cites W2045779236 @default.
• W2023231438 cites W2052446872 @default.
• W2023231438 cites W2067874044 @default.
• W2023231438 cites W2082306497 @default.
• W2023231438 cites W2092440654 @default.
• W2023231438 cites W2098176107 @default.
• W2023231438 cites W2121117803 @default.
• W2023231438 cites W2122927637 @default.
• W2023231438 cites W2130941707 @default.
• W2023231438 cites W2137373982 @default.
• W2023231438 cites W2144816570 @default.
• W2023231438 cites W2146778486 @default.
• W2023231438 cites W2160565595 @default.
• W2023231438 cites W2169064989 @default.
• W2023231438 cites W2169503293 @default.
• W2023231438 cites W2334476599 @default.
• W2023231438 cites W4236559684 @default.
• W2023231438 doi "https://doi.org/10.1111/j.1440-1827.2008.02320.x" @default.
• W2023231438 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19121088" @default.
• W2023231438 hasPublicationYear "2008" @default.
• W2023231438 type Work @default.
• W2023231438 sameAs 2023231438 @default.
• W2023231438 citedByCount "72" @default.
• W2023231438 countsByYear W20232314382012 @default.
• W2023231438 countsByYear W20232314382013 @default.
• W2023231438 countsByYear W20232314382014 @default.
• W2023231438 countsByYear W20232314382015 @default.
• W2023231438 countsByYear W20232314382016 @default.
• W2023231438 countsByYear W20232314382017 @default.
• W2023231438 countsByYear W20232314382018 @default.
• W2023231438 countsByYear W20232314382019 @default.
• W2023231438 countsByYear W20232314382020 @default.
• W2023231438 countsByYear W20232314382021 @default.
• W2023231438 countsByYear W20232314382022 @default.
• W2023231438 countsByYear W20232314382023 @default.
• W2023231438 crossrefType "journal-article" @default.
• W2023231438 hasAuthorship W2023231438A5010274378 @default.
• W2023231438 hasAuthorship W2023231438A5011873228 @default.
• W2023231438 hasAuthorship W2023231438A5017594552 @default.
• W2023231438 hasAuthorship W2023231438A5027999170 @default.
• W2023231438 hasAuthorship W2023231438A5039282044 @default.
• W2023231438 hasAuthorship W2023231438A5042679078 @default.
• W2023231438 hasAuthorship W2023231438A5053051266 @default.
• W2023231438 hasAuthorship W2023231438A5063847492 @default.
• W2023231438 hasAuthorship W2023231438A5068098421 @default.
• W2023231438 hasAuthorship W2023231438A5080880447 @default.
• W2023231438 hasAuthorship W2023231438A5083631538 @default.
• W2023231438 hasAuthorship W2023231438A5088282685 @default.
• W2023231438 hasAuthorship W2023231438A5091866467 @default.
• W2023231438 hasConcept C121608353 @default.
• W2023231438 hasConcept C126322002 @default.
• W2023231438 hasConcept C142724271 @default.
• W2023231438 hasConcept C167734588 @default.
• W2023231438 hasConcept C183713625 @default.
• W2023231438 hasConcept C204232928 @default.
• W2023231438 hasConcept C2777025900 @default.
• W2023231438 hasConcept C2778324911 @default.
• W2023231438 hasConcept C2779699572 @default.
• W2023231438 hasConcept C2781182431 @default.
• W2023231438 hasConcept C43060935 @default.
• W2023231438 hasConcept C502942594 @default.
• W2023231438 hasConcept C62478195 @default.

• next